Systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can reduce the amount of times the sensor goes offline. Systems and methods may factor in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.

An electronic cigarette vaporizer is not dis-assembled for filling with e-liquid, but is instead filled from a user-replaceable e-liquid cartridge. The vaporizer includes a front section comprising a wick and heating assembly but no e-liquid cartridge, the front section being removably fitted to a body of the vaporizer to enable a replacement front section to be used once the original wick or heating element starts to degrade, that replacement front section being supplied to the end-user with no e-liquid in it.

A coded collapsible drug reservoir and a drug delivery system including the coded collapsible drug reservoir. The drug reservoir includes a collapsible housing and a port in communication with the collapsible housing. The drug reservoir further includes a coding feature disposed on the drug reservoir, and the coding feature identifies the drug reservoir.

The invention is an electronic cigarette vaporizer system operable in a discrete mode to reduce the amount of vapor produced by a vaporizer that forms part of the system, compared to a normal mode. The discrete mode causes the vapor produced to be less visible or noticeable, compared to a normal mode.

An electronic cigarette vaporizer that includes a heating element and further includes or co-operates with an electronics module that (i) detects characteristics of the delivery of power, current or voltage to the heating element and (ii) determines if those characteristics are associated with degradation of the heating element. A characteristic that is associated with degradation of the heating element is an increase or other change in the heating element resistance. The heating element resistance can be established by the electronics module sending a test current through the heating element that is sufficient to enable a measurement of resistance to be made.

An electronic cigarette vaporizer includes a heating element for heating an e-liquid and a microcontroller; the microcontroller determines the type and/or characteristics of the e-liquid being used and uses that as an input to automatically control the power delivered to the heating element to heat the e-liquid in a manner suitable for that specific type of e-liquid, or e-liquid with those characteristics. The e-liquid can be supplied from a cartridge and that cartridge then includes a record of the type of e-liquid stored in the cartridge and/or its characteristics and the microcontroller reads that record or is provided data from that record. A variable for the type of e-liquid and/or its characteristics is the water content of the e-liquid.

An electronic cigarette vaporiser includes a heating element and a microcontroller; the microcontroller monitors or measures the airflow speed or pressure drop over an air-pressure sensor or other sensor and uses that as an input to control the power delivered to the heating element. The microcontroller can compensate for a very strong inhalation by applying more power during that inhalation as compared to a very light inhalation to ensure that the heating element is kept at its optimal heating temperature.

The invention relates to an injection device for injecting dosed amounts of a liquid therapeutic agent, comprising a receiving system for the therapeutic agent, an application system for transferring the therapeutic agent to an application site, a dosing system for transferring the therapeutic agent from the receiving system to the application system, a trigger system for activating the dosing system, and a detection system for detecting the amount of the therapeutic agent applied. According to the invention, a sensor arrangement comprises at least one recognition system which detects, prior to injection, whether the therapeutic agent has been mixed.

A patient care system is configured for infusing fluid to a patient. The system includes a plurality of modular fluid infusion pumps that each has a connector for connecting to a modular programming unit or to one another. Systems and methods are configured for verifying that the connectors are reliably performing their functions or communicatively connecting the pumps to one another or to the programming unit.

Systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can reduce the amount of times the sensor goes offline. Systems and methods may factor in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.